<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药前途汇 | wechat-feeds</title><link>http://MjM5NTI2NDUzNA.favicon.privacyhide.com/favicon.ico</link><description>全球医药技术和企业股权交易市场，2010年成立至今...</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 31 May 2021 14:54:30 +0800</pubDate><image><url>http://MjM5NTI2NDUzNA.favicon.privacyhide.com/favicon.ico</url><title>医药前途汇 | wechat-feeds</title><link>http://MjM5NTI2NDUzNA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>【相约成都】希比希“进口制剂技术、原料药、药用辅料”项目推荐</title><link>https://mp.weixin.qq.com/s/I0k0XuP5mq1upMWJ8JGB_w</link><description></description><content:encoded><![CDATA[【相约成都】希比希“进口制剂技术、原料药、药用辅料”项目推荐]]></content:encoded><pubDate>Mon, 31 May 2021 13:43:25 +0800</pubDate></item><item><title>【技术转让】工艺成熟的复杂制剂项目--注射用紫杉醇（白蛋白结合型）</title><link>https://mp.weixin.qq.com/s/nQhfSoLfDeZnA48GnQ_Z2Q</link><description></description><content:encoded><![CDATA[【技术转让】工艺成熟的复杂制剂项目--注射用紫杉醇（白蛋白结合型）]]></content:encoded><pubDate>Mon, 31 May 2021 13:43:25 +0800</pubDate></item><item><title>【制剂CMO】6大生产基地：京新药业提供国际标准的口服固体制剂CMO服务</title><link>https://mp.weixin.qq.com/s/n3Oy90pWN7lTMFV8GucTyQ</link><description></description><content:encoded><![CDATA[【制剂CMO】6大生产基地：京新药业提供国际标准的口服固体制剂CMO服务]]></content:encoded><pubDate>Fri, 28 May 2021 17:03:13 +0800</pubDate></item><item><title>【联合申报】两次被FDA认定为抗癌孤儿药的“伊立替康脂质体”成熟工艺转让</title><link>https://mp.weixin.qq.com/s/m8o7Mhm9SrZc8ERcZ2RWZg</link><description></description><content:encoded><![CDATA[【联合申报】两次被FDA认定为抗癌孤儿药的“伊立替康脂质体”成熟工艺转让]]></content:encoded><pubDate>Fri, 28 May 2021 17:03:13 +0800</pubDate></item><item><title>【企业发布】15个粉针剂“抗生素”生产批件MAH转让</title><link>https://mp.weixin.qq.com/s/692r0vmmBitaxR0OsORORg</link><description></description><content:encoded><![CDATA[【企业发布】15个粉针剂“抗生素”生产批件MAH转让]]></content:encoded><pubDate>Thu, 27 May 2021 11:29:03 +0800</pubDate></item><item><title>【相约成都】高端仿制药研发CRO--上海博悦生物产品推荐</title><link>https://mp.weixin.qq.com/s/KKbELY7pm77JjC9MEfKMGg</link><description></description><content:encoded><![CDATA[【相约成都】高端仿制药研发CRO--上海博悦生物产品推荐]]></content:encoded><pubDate>Thu, 27 May 2021 11:29:03 +0800</pubDate></item><item><title>【相约成都】英格尔医药│“数十个”原料药和制剂项目寻求合作</title><link>https://mp.weixin.qq.com/s/f0CT9YWwppJSTtuxXhjZQw</link><description></description><content:encoded><![CDATA[【相约成都】英格尔医药│“数十个”原料药和制剂项目寻求合作]]></content:encoded><pubDate>Wed, 26 May 2021 10:42:22 +0800</pubDate></item><item><title>国信医药助力北京大学全球健康学科发展</title><link>https://mp.weixin.qq.com/s/ne3eCvAMk7MRF4rlTfrHjw</link><description></description><content:encoded><![CDATA[国信医药助力北京大学全球健康学科发展]]></content:encoded><pubDate>Wed, 26 May 2021 10:42:22 +0800</pubDate></item><item><title>【相约成都】艾迪药业│承接口服固体/溶液/冻干/水针制剂委托生产业务</title><link>https://mp.weixin.qq.com/s/NcV49GsrE_rq1XwcuQkgBw</link><description></description><content:encoded><![CDATA[【相约成都】艾迪药业│承接口服固体/溶液/冻干/水针制剂委托生产业务]]></content:encoded><pubDate>Wed, 26 May 2021 10:42:22 +0800</pubDate></item><item><title>【会议快讯】从北京→成都，前途汇打造全球医药健康项目交易大平台</title><link>https://mp.weixin.qq.com/s/mEPll7M_k_YKEeCudCVNVw</link><description></description><content:encoded><![CDATA[【会议快讯】从北京→成都，前途汇打造全球医药健康项目交易大平台]]></content:encoded><pubDate>Fri, 21 May 2021 15:42:21 +0800</pubDate></item><item><title>百家企业“走进海步”专业交流活动成功举办！</title><link>https://mp.weixin.qq.com/s/OSOqY9tcNk5mn-KHKyZHXw</link><description></description><content:encoded><![CDATA[百家企业“走进海步”专业交流活动成功举办！]]></content:encoded><pubDate>Fri, 21 May 2021 15:42:21 +0800</pubDate></item><item><title>【走进海步医药】100个成熟制剂/原料药/中间体项目合作对接</title><link>https://mp.weixin.qq.com/s/m3U2TyqPkcBhazelLlyPHg</link><description></description><content:encoded><![CDATA[【走进海步医药】100个成熟制剂/原料药/中间体项目合作对接]]></content:encoded><pubDate>Mon, 17 May 2021 15:00:03 +0800</pubDate></item><item><title>【药学CRO】支持中美双报--亚瑟医药“合作产品清单”推荐</title><link>https://mp.weixin.qq.com/s/l8KJwkjcnd2Rdus8nYc6ZA</link><description></description><content:encoded><![CDATA[【药学CRO】支持中美双报--亚瑟医药“合作产品清单”推荐]]></content:encoded><pubDate>Mon, 17 May 2021 15:00:03 +0800</pubDate></item><item><title>【多肽CDMO】深圳市健元医药“多肽项目清单”推荐</title><link>https://mp.weixin.qq.com/s/GZmirRgpbvVxv5jOfw3RdA</link><description></description><content:encoded><![CDATA[【多肽CDMO】深圳市健元医药“多肽项目清单”推荐]]></content:encoded><pubDate>Mon, 17 May 2021 15:00:03 +0800</pubDate></item><item><title>【企业发布】香山堂制药15个优势品种（含4个独家）诚邀贴牌/销售合作</title><link>https://mp.weixin.qq.com/s/Qvcz5G6cifEoVrJLJIHFOA</link><description></description><content:encoded><![CDATA[【企业发布】香山堂制药15个优势品种（含4个独家）诚邀贴牌/销售合作]]></content:encoded><pubDate>Fri, 14 May 2021 10:01:40 +0800</pubDate></item><item><title>【可立即交接】CDE优先审评品种“盐酸左旋沙丁胺醇吸入溶液+原料”</title><link>https://mp.weixin.qq.com/s/1DLvrXcfuHa9q5FWEtYpjQ</link><description></description><content:encoded><![CDATA[【可立即交接】CDE优先审评品种“盐酸左旋沙丁胺醇吸入溶液+原料”]]></content:encoded><pubDate>Fri, 14 May 2021 10:01:40 +0800</pubDate></item><item><title>2021都正沙龙-首站济南丨改良型新药＆高端制剂前沿技术沙龙诚邀您的参加！</title><link>https://mp.weixin.qq.com/s/QJntVGo_je0fKemVHAd1zQ</link><description></description><content:encoded><![CDATA[2021都正沙龙-首站济南丨改良型新药＆高端制剂前沿技术沙龙诚邀您的参加！]]></content:encoded><pubDate>Fri, 14 May 2021 10:01:40 +0800</pubDate></item><item><title>【制剂CDMO】创诺集团制剂平台“MAH转让”产品推荐</title><link>https://mp.weixin.qq.com/s/iiOtqKHPp17cW6vUsCJU7Q</link><description></description><content:encoded><![CDATA[【制剂CDMO】创诺集团制剂平台“MAH转让”产品推荐]]></content:encoded><pubDate>Wed, 12 May 2021 13:09:21 +0800</pubDate></item><item><title>【企业发布】85个已上市药品生产批件合作（转让/代理销售/贴牌）</title><link>https://mp.weixin.qq.com/s/BoJm7fHel6O_Uxml0fK_Lw</link><description></description><content:encoded><![CDATA[【企业发布】85个已上市药品生产批件合作（转让/代理销售/贴牌）]]></content:encoded><pubDate>Wed, 12 May 2021 13:09:21 +0800</pubDate></item><item><title>100家药企【走进海步医药】化学原料药和制剂项目合作交流对接</title><link>https://mp.weixin.qq.com/s/etzahMS2MeehSi67osebiQ</link><description></description><content:encoded><![CDATA[100家药企【走进海步医药】化学原料药和制剂项目合作交流对接]]></content:encoded><pubDate>Tue, 11 May 2021 09:27:46 +0800</pubDate></item></channel></rss>